The molecule’s structure explains both its power and its problems. Astaxanthin possesses an extended conjugated polyene chain terminated by two polar rings, each bearing hydroxyl and keto groups. This architecture lets the molecule span lipid membranes, anchoring at the surface while the chain sits within the bilayer, where it can intercept reactive oxygen species on both the aqueous and lipid sides. But the polyene chain is also the site of vulnerability: each double bond can undergo oxidation, isomerization or cleavage when exposed to oxygen, elevated temperature or ultraviolet radiation. For food formulators, this means that an astaxanthin-rich ingredient can lose its color and its bioactivity during baking, pasteurization or months of retail shelf storage, a constraint that has historically kept the pigment confined to high-value niches such as aquafeed.

Not all astaxanthin is chemically identical, and the review places unusual emphasis on stereochemistry. The molecule exists in three stereoisomeric configurations, and the 3S,3’S form, produced naturally by the green microalga Haematococcus pluvialis, is described as the predominant bioactive configuration. Synthetic astaxanthin, manufactured by chemical synthesis for the feed industry, arrives as a mixture of isomers with different biological behavior. Beyond chirality, the geometry of the central chain matters too: the all-E (trans) configuration dominates in natural sources, but processing can convert a fraction of it to Z (cis) isomers, which are more soluble and, in some contexts, more bioavailable. Work cited in the review found that Z-isomer-rich diets enhanced egg yolk pigmentation in laying hens more effectively than all-E-rich diets, a finding that turns isomerization from a degradation problem into a potential design tool.

Esterification adds another layer of complexity. In Haematococcus and in shrimp by-products, much of the astaxanthin occurs as monoesters and diesters, with fatty acids attached to the hydroxyl groups on the terminal rings. These esters are generally more stable than the free molecule, and the attached fatty acids can influence both antioxidant performance and digestibility. Chromatographic analyses of shrimp and algal extracts have mapped these ester profiles in detail, and the review argues that understanding the ester composition of a given source is essential for predicting how it will behave in a food matrix. Free astaxanthin from the yeast Phaffia rhodozyma, by contrast, is unesterified, which simplifies formulation but may alter its stability and uptake.

Where does industrial astaxanthin actually come from? The review surveys three biological workhorses. Haematococcus pluvialis, a freshwater microalga that accumulates astaxanthin esters in thick-walled cyst cells when stressed by light and nutrient deprivation, remains the richest natural source and the dominant route for human nutraceutical products. The red yeast Phaffia rhodozyma (also called Xanthophyllomyces dendrorhous) offers fast fermentation in bioreactors and free, unesterified pigment, making it attractive for feed and increasingly for food applications. The bacterium Paracoccus carotinifaciens provides a dried cell powder used directly in animal diets. Meanwhile, shrimp processing waste, heads and shells that would otherwise be discarded, represents a circular-economy opportunity, with ultrasound-assisted extraction into vegetable oils, including extra virgin olive oil, demonstrating both good recovery and successful incorporation into functional foods with strong consumer acceptance.

Getting the pigment out of these tough biological matrices is half the battle. Haematococcus cysts are notoriously resistant, encased in a robust cell wall that must be disrupted before any solvent can reach the pigment. The review catalogs a progression of cell-disruption and extraction technologies: high-pressure homogenization, which physically fractures the cyst wall; pulsed electric fields, which permeabilize membranes and can trigger enzymatic processes that loosen the matrix; ultrasound-assisted extraction, which uses cavitation to accelerate mass transfer; and subcritical fluid extraction, which has been applied to yeast biomass after cell wall breaking. On the solvent side, green chemistry is displacing petrochemical solvents. Supercritical carbon dioxide with ethanol as a co-solvent extracts astaxanthin and lutein from red-phase algal biomass without leaving toxic residues, while deep eutectic solvents and ionic liquids have shown strong performance against conventional organic solvents, including acidic deep eutectic systems applied directly to Haematococcus biomass. Notably, one strategy recovered astaxanthin at high yield directly from wet algal biomass without any drying pretreatment, a potentially significant energy saving given how expensive dewatering microalgae can be.

Extraction, however, only delivers a fragile molecule into a hostile world, and the review devotes substantial attention to keeping astaxanthin intact. Microencapsulation is the workhorse: embedding the pigment in protective matrices of proteins, polysaccharides or lipid carriers shields it from oxygen and light. Researchers have produced food-grade microcapsules using vibrating nozzle technology, which generates uniform particles suitable for large-scale production, and have shown that the fatty acid composition of the encapsulating oil affects the kinetic stability of both astaxanthin and co-encapsulated alpha-tocopherol during storage. Stability testing in model food systems confirms the practical stakes, with incorporation and retention varying widely depending on the matrix, processing conditions and packaging. The message for manufacturers is that astaxanthin cannot simply be stirred into a recipe; it must be engineered into the product.

The most technically ambitious frontier is nanoscale delivery. Because astaxanthin is lipophilic and poorly water-soluble, its oral bioavailability is low, limited by micellar solubilization in the gut and by degradation en route. Nano-delivery systems attack this bottleneck directly. Nanoemulsions, nanoliposomes, lipid nanoparticles and polymeric nanocarriers can disperse the pigment in aqueous foods, protect it during digestion and improve its uptake by intestinal cells. The review highlights examples with almost pharmaceutical precision: a microenvironment-responsive pod-structured nanocarrier designed to release astaxanthin in the inflamed gut, where it ameliorated inflammatory bowel disease in experimental models, and a nano-lipidic astaxanthin formulated in a thermoreversible gel that showed efficacy in a model of drug-induced Parkinsonism. In the cosmetic sphere, astaxanthin-zeaxanthin nanoemulsions have been formulated into radiance serums evaluated for stability and anti-wrinkle activity, building on earlier clinical work showing cosmetic benefits and topical antioxidant protection for skin.

In animal agriculture, astaxanthin’s roles are both aesthetic and physiological. In aquaculture, it is indispensable: salmonids and other farmed fish cannot synthesize carotenoids and must obtain pigmentation from their diet, and the pigment also supports reproduction and survival. Supplementation studies show broader benefits, including enhanced hemato-biochemical parameters and innate immunity in Asian seabass, improved growth, immunity and tissue composition in largemouth bass, and better antioxidant capacity, immunity and disease resistance in coral trout. In poultry, dietary astaxanthin from red yeast improved growth performance, meat quality and even reduced fecal noxious gas emissions in broilers, while microalgae-derived astaxanthin improved cytoprotective capacity in the intestines of heat-stressed birds and benefited the gut health of yellow-feathered broilers. In laying hens, moderate and high dose supplementation trials have assessed responses in yolk pigmentation and physiology, with Z-isomer-rich formulations outperforming conventional all-E forms in yolk color enhancement.

The livestock evidence extends to mammals facing one of modern farming’s chronic challenges: heat stress. Astaxanthin supplementation ameliorated simulated heat stress in Sirohi goats by regulating physio-biochemical responses, altered muscle antioxidant activity and meat quality in broilers exposed to high ambient temperatures, reduced oxidative stress in sows with positive effects on piglet growth, improved antioxidant status and immunity in growing buffalo heifers when paired with copper, and even preserved sperm quality and antioxidant capacity in stored ram semen. Taken together, the review frames astaxanthin as a versatile tool for an agro-food sector grappling with climate pressure, consumer demand for natural ingredients and the valorization of processing waste. The obstacles that remain, cost-competitive production, scalable green extraction, and delivery systems that survive real-world food processing, are precisely the areas where the 2000 to 2025 literature shows the fastest movement, suggesting that the molecule once prized mainly for making salmon pink may soon be engineered into a far wider range of foods, feeds and therapies.

Subject of Research: Advances in astaxanthin sources, green extraction, stabilization, nano-delivery systems and nutritional applications in the agro-food industry

Article Title: Astaxanthin in the agro-food industry: advances in sources, processing, delivery systems, and nutritional applications

Article References: Astaxanthin in the agro-food industry: advances in sources, processing, delivery systems, and nutritional applications. (n.d.). https://doi.org/10.1007/s10068-026-02345-z

Image Credits: AI Generated

DOI: 10.1007/s10068-026-02345-z

Keywords: astaxanthin, carotenoid, antioxidant, Haematococcus pluvialis, green extraction, nano-delivery systems, bioavailability, microencapsulation, aquaculture, animal feed, nutraceuticals, food science

The material at the heart of the study comes from the sponge Haliclona sp., whose skeleton is built from spicules—slender, needle-shaped rods of biosilica. In earlier work, the same group showed that intact spicules, massaged briefly into the skin, create dense fields of nanometer-scale microchannels that boost penetration of small drugs. Those channels, however, proved too narrow for biomacromolecules, which typically range from a few to hundreds of kilodaltons. The researchers’ new idea was to etch the spicules themselves, dissolving away the tip and, unexpectedly, the entire axial core to leave a continuous hollow channel running the length of each needle. This transformation converts each spicule from a solid puncturing pin into something closer to a microscopic drinking straw embedded in the skin.

Manufacturing the hollow structures required careful optimization of an alkaline etching process. The team immersed purified spicules in sodium hydroxide solutions of varying concentration and duration, then evaluated how many spicules developed open tips, how large the resulting channels were, and whether the etched structures retained the mechanical strength needed to pierce skin. The harshest condition tested—2 molar sodium hydroxide for 72 hours—produced the widest openings and highest opening rates but visibly degraded structural integrity. The sweet spot turned out to be 2 molar NaOH for 48 hours, which maximized hollow-channel formation while preserving the spicules’ ability to withstand handling and skin insertion. Scanning electron microscopy of cross-sections taken at the tip, mid-shaft, and base revealed a continuous internal lumen, and confocal microscopy after Nile Red staining confirmed that the channels readily admit fluid and dissolved compounds.

The etching pattern itself has an elegant biological explanation. Siliceous sponge spicules are built around a proteinaceous axial filament, and the alkaline treatment appears to preferentially dissolve along this central core, carving out the hollow channel along a pre-existing biological template. This means the manufacturing process exploits the sponge’s own architecture rather than fighting it—a rare example of a natural biomaterial being upgraded through a one-step chemical modification into something functionally analogous to an engineered hollow microneedle array, but without any of the cleanroom microfabrication that synthetic microneedles demand.

With the hollow spicules in hand, the researchers benchmarked them against a formidable lineup of competitors in Franz diffusion cell experiments using fresh porcine skin: intact spicules, conventional microneedle patches, dermaroller devices, iontophoresis, and plain subcutaneous injection. For sodium fluorescein, a small hydrophilic tracer, hollow spicules alone achieved total skin absorption of roughly 24 percent, rising to nearly 43 percent when paired with a 15-minute course of low-current iontophoresis. The combination produced a synergistic index of 1.44, meaning the two techniques together outperformed the sum of their individual effects. For larger fluorescent dextrans of 20, 40, and 150 kilodaltons, the gap widened dramatically. With the 20-kilodalton dextran, hollow spicules plus iontophoresis pushed absorption to about 35 percent with a synergistic index of 3.29, while intact spicules combined with iontophoresis showed no synergy at all—clear evidence that the hollow channels, not merely the puncture sites, were doing the heavy lifting.

Dose dependence and distribution uniformity emerged as two further advantages. When the team varied the amount of hollow spicules applied, penetration of the 150-kilodalton dextran scaled accordingly, giving clinicians a tunable knob for dosing. More striking was the spatial pattern: biomacromolecules delivered through spicule-treated skin spread evenly across the entire treated area, with no significant concentration differences among randomly sampled sites. Subcutaneous injection, by contrast, produced a hot spot at the needle entry point with essentially no detectable drug 5 millimeters or 1 centimeter away. For depot drugs, that pooling is sometimes desirable, but for vaccines and immunotherapies meant to engage skin-resident immune cells, uniform distribution could translate into more consistent uptake and fewer local adverse effects.

The platform’s most clinically resonant demonstration involved an antibody fragment. The team compared hollow spicules against laboratory-fabricated dissolving microneedle patches—10-by-10 arrays of quadrangular pyramidal needles, each about 820 micrometers tall and mechanically robust enough to withstand roughly 0.8 newtons of compressive force—for delivering a shark-derived anti-PD-L1 variable new antigen receptor, a model antibody-like therapeutic. The hollow spicules achieved total skin absorption of about 25 percent, roughly doubling the microneedle patch result of 11.5 percent and more than quadrupling the untreated control. Because antibody drugs represent one of the fastest-growing classes of biologics yet remain almost entirely injection-bound, a topical route that outperforms microneedles would be a meaningful advance for patients who self-administer these therapies.

To test whether the effect matters biologically, not just chemically, the researchers delivered ovalbumin, a classic model antigen, to guinea pigs over consecutive days and tracked immune activation. Both the injection group and the hollow-spicule group showed visible immune reactions by day 2, and by day 8 the spicule group’s responses, while milder than injection, remained significantly stronger than controls and intact-spicule groups. Blood analysis told the same quantitative story: ovalbumin-specific IgE levels were markedly elevated in the spicule group, and interleukin-4 concentrations showed no significant difference from the injection group. In other words, a topical massage of sponge-derived microneedles provoked an immune response functionally comparable to a needle in the flesh—a result with obvious implications for needle-free vaccination.

Safety data were encouraging but appropriately caveated. Mild redness and swelling after application resolved within 48 to 72 hours, and histological counts of immune cells in treated skin spiked to roughly 550 cells per analyzed region at 24 and 48 hours before falling back to baseline levels by day 10, statistically indistinguishable from untreated controls. Repeated application produced no chronic inflammatory infiltration, and examination of major organs revealed no abnormalities. The authors are candid, however, about a longer-term concern: silica is a recognized granulomatogenic material, and cutaneous silica granulomas can appear months or even years after exposure. Their 10-day observation window cannot rule out such delayed reactions, and the team calls for extended follow-up studies, including polarized-light assessment for birefringent particles, before the platform moves toward human use.

The study also contributes a quantitative framework for predicting how drugs will behave under spicule treatment. Because hollow spicules remain embedded in skin during use, they generate annular channels rather than the funnel-shaped perforations left by removable microneedles. Building on established microporous-skin permeability models, the researchers derived and fitted an equation capturing the dependence of permeability on molecular weight and oil-water partitioning across six test compounds, with the expected inverse relationship to molecular weight dominating the tested range. The team notes that validation in ex vivo human skin and clinical studies will be essential, since animal skin differs from human skin in barrier structure and immune responsiveness. Still, the combination of natural abundance, batch-to-batch dimensional consistency, low manufacturing cost, tunable dosing, uniform drug spread, and demonstrated vaccine-grade immune activation makes hollow sponge spicules one of the more compelling entries yet in the race to retire the hypodermic needle.

Subject of Research: Transdermal delivery of biomacromolecules using hollowed marine sponge spicules as natural microneedles

Article Title: Enhanced skin delivery of biomacromolecules using hollow sponge spicules

Article References: Mou, D., Yang, M., Jia, M., Liu, Y., Chen, J., Xiao, X., & Chen, M. (2026). Enhanced skin delivery of biomacromolecules using hollow sponge spicules. Bioengineering & Translational Medicine, 11(5), Article e70149. https://doi.org/10.1002/btm2.70149

Image Credits: AI Generated

DOI: 10.1002/btm2.70149

Keywords: drug delivery, microneedles, sponge spicules, transdermal, biomacromolecules, vaccination, biologics, iontophoresis, biosilica, skin barrier, antibody delivery, marine biotechnology

What makes marine carbohydrates so chemically interesting is their structural diversity. Polysaccharides extracted from seaweeds, sponges, shellfish and marine bacteria can carry sulfate groups in patterns that differ from species to species, form glycosidic linkages that are uncommon in terrestrial plants, and adopt branched architectures that change how they interact with biological targets. Fucoidans from brown algae, carrageenans from red algae, chitin and chitosan derivatives from crustacean shells, and sulfated glycosaminoglycan-like molecules from marine animals all fall into this category. Because the precise arrangement of sulfate groups and sugar units determines how these molecules bind to proteins, enzymes and cell surfaces, even subtle structural differences can translate into dramatically different biological effects.

That sensitivity to structure is precisely why these molecules have attracted attention across so many therapeutic areas. The review documents reported antiviral, anticoagulant, immunomodulatory and antitumor activities for marine-derived carbohydrates and their derivatives, alongside material properties that make them useful in drug delivery systems, wound dressings and tissue engineering scaffolds. Sulfated polysaccharides, for example, can interfere with viral attachment and entry by mimicking the charged surfaces that viruses normally latch onto, while alginate-based materials have become mainstays in encapsulation and wound-care applications because of their gentle gelling behavior and biocompatibility.

The clinical story of marine-inspired drugs is older than many readers might expect. The review’s authors anchor their timeline to cytarabine, an antileukemia drug approved in the United States in 1969, which traces its chemical inspiration to nucleosides originally isolated from a Caribbean sponge. Although cytarabine is not itself a carbohydrate in the polysaccharide sense, it established a crucial precedent: molecules derived from marine organisms could survive the full gauntlet of preclinical testing, regulatory scrutiny and clinical use. Later products built on alginate, carrageenan and other marine raw materials followed, extending the family of carbohydrate-based medicines into areas such as wound management, drug formulation and symptomatic treatment.

Today, the pipeline is broader than ever. The review surveys clinical-stage candidates derived from marine carbohydrates currently being evaluated for viral infections, cancer, metabolic disorders, tissue repair, cystic fibrosis and neurological disease. This breadth reflects both the versatility of the molecules and the maturity of the field: what was once a collection of exploratory extracts has become a portfolio of defined candidates moving through controlled trials. Yet the authors are careful to note that the distance between a promising laboratory result and an approved product remains substantial, and that the obstacles are not primarily about discovering new activities.

The central challenge, according to the review, is reproducibility. The biological activity of a marine polysaccharide depends on its molecular weight, its sulfation pattern and its monosaccharide composition, but all three of these parameters can vary with the species from which the material is harvested, the season in which it is collected, and the extraction and processing methods used to isolate it. A batch of fucoidan gathered from one coastline in spring may differ measurably from a batch of the nominally same polymer collected elsewhere in autumn. For a regulatory agency, such variability is a serious problem, because a drug must deliver the same molecule, with the same quality attributes, every single time.

Solving that problem requires the kind of systematic thinking that the review tries to encourage. The authors argue that marine carbohydrates have too often been studied in terms of individual biological activities, with each research group reporting a single effect in isolation, while clinical development demands an integrated understanding of how structure, production, quality control and mechanism of action fit together. A candidate cannot advance if researchers cannot define its composition precisely, manufacture it consistently and explain how it works at the molecular level. The review therefore treats approved drugs and clinical candidates not just as success stories, but as case studies in how these elements can be aligned.

The priorities for future development that the authors identify are correspondingly practical. They call for reliable production methods based on cultivation, fermentation or enzymatic processing, which would decouple drug supply from wild harvesting and reduce batch-to-batch variation. They emphasize the need for improved quality control that combines structural characterization with activity-based assays, so that manufacturers can verify not only what a batch contains but what it does. They also stress the importance of validating molecular targets and mechanisms of action, and of conducting more rigorous pharmacokinetic and safety studies, areas in which complex carbohydrates have historically lagged behind small-molecule drugs because of their size, heterogeneity and analytical difficulty.

Achieving these goals, the review concludes, will require collaboration across disciplines that do not always work together. Senior and co-corresponding author Guangli Yu of the Ocean University of China notes that progress will depend on close cooperation among researchers in glycoscience, analytical chemistry, synthetic biology, materials science and clinical research. Co-corresponding author Chao Cai, also of the Ocean University of China, shares responsibility for the work, which was conducted within the Key Laboratory of Marine Drugs under the Ministry of Education and the Shandong Key Laboratory of Glycoscience and Glycotherapeutics. The interdisciplinary framing is deliberate: no single field currently possesses all the tools needed to characterize, manufacture and clinically validate a heterogeneous natural polymer.

The significance of the review lies less in any single discovery than in its synthesis. By following a clinical timeline that stretches from a 1969 leukemia drug to today’s trials in virology, oncology, metabolic disease and neurology, it demonstrates that marine carbohydrate therapeutics are not a speculative frontier but an evolving branch of pharmacology with a documented track record. The structural uniqueness of ocean-derived sugars, once a curiosity, is now understood as a design resource, and the field’s remaining challenges are the familiar ones of manufacturing, characterization and clinical evidence. If the collaborative agenda the authors describe takes hold, the next chapters of this timeline may be written not by chance discoveries in tide pools, but by engineered production systems capable of delivering the ocean’s chemistry with pharmaceutical precision.

Subject of Research: Marine carbohydrate-based drug development and clinical translation

Article Title: Marine carbohydrate therapeutics: from structural diversity to clinical translation

Article References: Marine carbohydrate therapeutics: from structural diversity to clinical translation. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: marine carbohydrates, polysaccharides, fucoidan, alginate, carrageenan, drug development, clinical trials, glycoscience, sulfation, antiviral, anticoagulant, Ocean University of China

Aldolase catalyzes the fourth step of glycolysis, cleaving fructose-1,6-bisphosphate into two three-carbon sugars, glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Because these triose phosphates feed both the lower half of glycolysis and the glycerol backbone used to build lipids, the enzyme sits at a critical junction of central carbon metabolism. Most of what is known about aldolase comes from medical research, particularly cancer biology, where studies have shown that blocking aldolase can push glucose-6-phosphate into the pentose phosphate pathway, increasing the production of NADPH, the reducing power that cells use for biosynthesis. The Xiamen University team, led by Yiting Zhang and Xueping Ling, asked whether the same logic could be applied to a microbe whose entire commercial value depends on how much reducing power and carbon skeleton it can pour into fatty acid synthesis.

To find out, the researchers constructed a knockout strain by replacing the aldolase gene, designated ALDOA, with a bleomycin resistance cassette through homologous recombination. They amplified roughly 420-base-pair sequences flanking the gene, ligated them into the pBlue-zeo plasmid around the resistance marker, and introduced the construct into wild-type cells by electroporation. Transformants were selected on plates containing 50 milligrams per liter of bleomycin, and PCR sequencing of the homologous arms confirmed that the native gene had been successfully replaced. The resulting strain, called ΔALDOA, was then compared with the wild type over a 168-hour shake-flask fermentation using glucose-based medium.

The immediate consequences of the deletion were negative for bulk productivity. Final biomass in the knockout strain was 9.6 percent lower than the wild-type maximum, and total lipid production fell by 23.2 percent. During active growth the deficits were even larger: at 96 hours the mutant’s cell dry weight was up to 40.61 percent below the wild type, and at 72 hours its lipid yield lagged by as much as 49.34 percent. Glucose consumption told a similar story. The wild-type strain essentially exhausted the sugar supply by 120 hours, whereas the knockout had used only about half of it at that point and needed until 168 hours to finish. Intriguingly, the mutant actually consumed glucose faster than the wild type in the earliest phase of cultivation, apparently ramping up overall metabolism to compensate for the metabolic bottleneck, before its impaired glycolysis caught up with it in the middle and later stages.

The fatty acid composition, however, moved in a very different direction. At 120 hours the proportion of saturated fatty acids in the knockout strain was about 17.4 percent lower than in the wild type, driven mainly by reductions in the C16:0 and C14:0 species. Polyunsaturated fatty acids, including DHA, docosapentaenoic acid, and eicosapentaenoic acid, rose by 28.0 percent overall, with DHA itself up 22.9 percent and EPA up a remarkable 75.0 percent. When the team broke the lipid pool down into triglycerides and phospholipids, they found that polyunsaturated fatty acids are mostly stored in triglycerides, at 35 to 48 percent of that fraction, while phospholipids carry 10 to 15 percent and contain no detectable EPA at all. The knockout boosted the polyunsaturated content of triglycerides specifically, with DHA rising 27.4 percent at 72 hours and 20.8 percent at 120 hours, while the main saturated species, C16:0, dropped by 46.5 percent and 36.0 percent at the same time points.

Phospholipidomics provided a mechanistic explanation rooted in how DHA travels through the cell. Phosphatidylcholine, the most abundant phospholipid in Schizochytrium at roughly half of the total, is known to be the first docking site for newly synthesized DHA before the fatty acid is transferred to triglycerides for storage. In the knockout strain, the proportion of phosphatidylcholine was 11.5 percent higher than the wild type at 72 hours and 7.5 percent higher at 120 hours, and lysophosphatidylcholine, its precursor in the glycerophosphorylcholine acylation pathway, reached 4.8 times the control level at 72 hours. Meanwhile, phosphatidylglycerol, a phospholipid tied to cell growth, collapsed by 92.2 percent at 72 hours, and phosphatidylinositol, phosphatidylserine, and phosphatidic acid all declined as well. Because these species are built through the Kennedy pathway from dihydroxyacetone phosphate-derived precursors, their depletion directly reflects the loss of aldolase activity upstream.

Gene expression analysis reinforced the picture. Transcripts of the fatty acid synthase gene, which produces saturated fatty acids, fell in the mutant, while the chain length factor gene of the anaerobic polyketide synthase cluster, responsible for elongating polyunsaturated chains, rose sharply in the middle and later stages of fermentation. The gene for glucose-6-phosphate dehydrogenase, the gateway enzyme of the pentose phosphate pathway, followed a similar pattern, indicating enhanced flux through that route and a greater supply of NADPH for fatty acid desaturation and elongation. Transcripts of phosphatidic acid phosphatase and diacylglycerol acyltransferase, the enzymes that convert phosphatidic acid into triglycerides via the Kennedy pathway, decreased, whereas the genes for phospholipid diacylglycerol choline phosphate transferase, or PDAT, and lysophosphatidylcholine acyltransferase, or LPCAT, were strongly upregulated. Together these shifts suggest the mutant builds its triglycerides increasingly through the phosphatidylcholine route, shuttling DHA from phospholipid storage into neutral lipid reserves.

Metabolomics by gas chromatography-mass spectrometry identified 35 differential metabolites that mapped the rewiring across glycolysis, the tricarboxylic acid cycle, the pentose phosphate pathway, and amino acid and sterol synthesis. Sugar alcohols associated with the oxidative pentose phosphate route surged, with arabitol up 4.06-fold and ribitol up 7.84-fold at 120 hours. The knockout strain also accumulated protective metabolites: inositol, a signaling molecule against oxidative stress, rose threefold, and mannitol, a hydroxyl radical scavenger, increased 1.23-fold, while glycine rose to supply precursors for glutathione synthesis. Flow cytometry using a fluorescent probe confirmed that reactive oxygen species were lower in the mutant at both measured time points. Since polyunsaturated fatty acids are vulnerable to free-radical oxidation, the reduced oxidative environment plausibly helps preserve the DHA the cells do make, complementing the increased reducing power available for synthesizing it in the first place.

The authors propose a coherent metabolic model: deleting ALDOA weakens glycolysis and the TCA cycle, slowing growth, and starves the Kennedy pathway of dihydroxyacetone phosphate, cutting total lipid and phospholipid output. In compensation, carbon is pushed into the pentose phosphate pathway, raising NADPH for polyunsaturated fatty acid synthesis, while the cell reinforces the glycerophosphorylcholine acylation route and PDAT-mediated transfer so that more DHA is bound to phosphatidylcholine and then moved into triglycerides. The trade-off is clear, with less biomass but a richer omega-3 profile per cell. The team notes that future work using CRISPR or RNA interference to tune, rather than abolish, aldolase expression could improve DHA accumulation without the growth penalty, offering a new metabolic engineering strategy for one of the world’s most important microbial oil producers.

Subject of Research: Aldolase gene disruption and carbon flux redistribution for DHA synthesis in Schizochytrium

Article Title: Functions of aldolase in lipid synthesis of Schizochytrium sp. by gene disruption to switch carbon metabolism

Article References: Zhang, Y., Wu, X., Guo, X., Li, K., Lu, Y., Lin, X., & Ling, X. (2024). Functions of aldolase in lipid synthesis of Schizochytrium sp. by gene disruption to switch carbon metabolism. Blue Biotechnology, 1(1), Article 17. https://doi.org/10.1186/s44315-024-00014-6

Image Credits: AI Generated

DOI: 10.1186/s44315-024-00014-6

Keywords: Schizochytrium, aldolase, DHA, polyunsaturated fatty acids, glycolysis, pentose phosphate pathway, carbon flux, metabolic engineering, phospholipids, triglycerides, NADPH, marine biotechnology

The research team, led by Danhong Ge, YangYang Luo, Ruyu Zhang, Xuechao Hu, and Lujing Ren, set out to answer a deceptively simple question: what happens when you expose a microbe that normally grows in the dark to sustained light stress? Schizochytrium sp. HX-308, the strain used in the study, was isolated from seawater and deposited in the China Center for Type Culture Collection. In industrial settings it is typically fermented in large, dark vessels where it converts glucose into a lipid-rich biomass. Light, in this context, is usually treated as an irrelevance or even a nuisance. The new study suggests that assumption deserves a second look, because light turns out to be a powerful abiotic stress factor that reprograms the cell’s entire metabolic priorities.

The researchers divided the fermentation process into three distinct phases: a cell growth stage from zero to forty-eight hours, a lipid accumulation stage from forty-eight to ninety-six hours, and a lipid turnover stage from ninety-six to one hundred forty-four hours, when the cells begin consuming their own stored fat reserves. Under normal dark conditions, the culture reached a maximum cell dry weight of 50.5 grams per liter at seventy-two hours. When the flasks were illuminated with an array of LED strips delivering a total luminous flux of 18,311.4 lumens, growth slowed noticeably. Glucose consumption was delayed, the fermentation cycle stretched from seventy-two to ninety-six hours, and the peak biomass fell to 41.3 grams per liter, a reduction of 18.21 percent compared with the dark-grown control.

Microscopy revealed that the light-exposed cells were visibly different from their dark-grown counterparts. They grew larger in diameter, became more dispersed and independent in their morphology, and accumulated more prominent lipid droplets as the fermentation progressed. Using propidium iodide staining under a confocal fluorescence microscope, the team showed that cell membrane damage was consistently higher under light stress, peaking at ninety-six hours, precisely when the lipid turnover phase begins. The researchers hypothesize that the enlarged cell diameter is an adaptive response, allowing the organism to meet the elevated energy and material demands imposed by the stressful environment. Similar light-induced changes in cell size have been documented in diatoms such as Ditylum brightwellii, suggesting this may be a widespread strategy among marine microbes.

The real surprise came when the team measured what the cells were actually producing. Although the light-stressed cultures grew more slowly, their final lipid yield reached 8.45 grams per liter, a striking 39.67 percent higher than the 6.05 grams per liter measured in the control after the turnover phase had run its course. The delayed glucose consumption appears to slow the onset of lipid turnover, effectively extending the window during which the cells hold onto their oil. In other words, the stress that cost the microbe some of its growth paid off handsomely in the currency that industry actually cares about: stored lipid that survives to the end of the fermentation.

The composition of that lipid changed too, and in commercially interesting directions. Saturated fatty acids, particularly myristic acid (C14:0) and palmitic acid (C16:0), were 1.49 times more abundant in the light-treated group, reaching 4.97 percent and 15.86 percent of the total fatty acid pool respectively. Saturated fats of this kind are the raw material for neutral lipid formation and have their own market in oleochemical applications. Meanwhile, the polyunsaturated fatty acids docosapentaenoic acid and DHA declined modestly, from 24.74 percent and 59.14 percent in the control to 20.59 percent and 56.28 percent under light. But eicosapentaenoic acid, or EPA, an omega-3 fatty acid with anti-inflammatory applications and a notoriously difficult production process, jumped from 2.14 percent to 8.30 percent of total fatty acids, a 3.88-fold increase that caught the researchers’ attention.

Beyond the fatty acids, light stress proved to be a potent trigger for two of the microbe’s most valuable secondary metabolites. Squalene, a terpenoid used in cosmetics, vaccines, and pharmaceutical formulations, peaked at 67.46 milligrams per liter at seventy-two hours under light stress, compared with 55.67 milligrams per liter at forty-eight hours in the dark, and the light-stressed cultures sustained higher squalene levels through the later stages of fermentation, ending 21.17 percent above the control. Beta-carotene followed a similar pattern, peaking at roughly 7,184 micrograms per liter at ninety-six hours under light versus 5,368 micrograms per liter at seventy-two hours in the dark. By the end of fermentation, the light-stressed cultures contained 5,675 micrograms per liter of beta-carotene, 4.75 times the control level. Astaxanthin, a premium carotenoid synthesized downstream of beta-carotene, rose continuously throughout the light-stressed fermentation, finishing nearly 2,081 micrograms per liter, 11.39 percent above the control, and its accumulation only accelerated after beta-carotene had peaked, consistent with beta-carotene serving as a metabolic precursor.

To understand why light produces these effects, the team measured intracellular reactive oxygen species and performed a full transcriptomic analysis using Illumina RNA sequencing. Light stress elevated oxidative pressure inside the cells, but the light-stressed cultures actually showed lower peak ROS levels than the controls, indicating that the organism mounts a robust antioxidant defense. The transcriptome told the molecular story. A core set of 226 differentially expressed genes was shared across all light-versus-dark comparisons, while the 144-hour comparison alone revealed 788 unique light-responsive genes. At seventy-two hours, light stress predominantly suppressed metabolic genes, an acute stress response; by 144 hours, the pattern flipped to widespread upregulation, signaling a transition to long-term metabolic reprogramming. Gene ontology analysis showed marked enrichment of genes involved in stimulus response, antioxidant activity, and transporter activity under light, while genes for lipid biosynthesis and antioxidant processes became dominant at the later time point.

The pathway-level details are particularly revealing. In the mevalonate pathway, which supplies the building blocks for isoprenoids such as squalene, the enzyme isopentenyl diphosphate isomerase was significantly upregulated under light, especially at 144 hours, along with farnesyl diphosphate synthase and squalene synthase, the enzymes that assemble farnesyl diphosphate into squalene itself. Fatty acid metabolism showed a dual pattern: acetyl-CoA carboxylase and fatty acid synthase were upregulated, driving carbon toward palmitic acid, while a key beta-oxidation gene was downregulated, meaning the cells burned less of the fat they stored. Intriguingly, glycolysis genes were suppressed, suggesting the microbe rerouted carbon flux away from rapid energy production and toward lipid and terpenoid biosynthesis, a strategy that mirrors engineered lipid-boosting interventions in other microalgae. The upregulated polyketide synthase genes hint at the channeling of resources toward EPA production, which supports membrane fluidity under stress.

For the biotechnology industry, the implications are considerable. Light is an inexpensive, non-invasive, and precisely controllable stimulus compared with chemical additives or genetic engineering, and this study demonstrates that it can simultaneously raise lipid yield, enrich EPA, and boost squalene and carotenoid production in a single fermentation run. The trade-off, a longer fermentation cycle and lower biomass, is a real cost, but the researchers argue that the metabolic insights gained here, particularly the coordinated upregulation of the mevalonate pathway and the suppression of fatty acid degradation, could guide further optimization, whether through tuned light regimens, light combined with other stressors, or targeted engineering of the genes identified in the transcriptome. As demand for omega-3 oils and natural antioxidants continues to climb, the idea that a well-placed bank of LED strips could coax more value out of every liter of fermentation broth is an appealingly simple proposition, and one that this marine microbe appears ready to deliver on.

Subject of Research: Effect of light stress on lipid, fatty acid, squalene, and carotenoid biosynthesis in the marine protist Schizochytrium sp.

Article Title: Effect of light stress on the production of lipid compounds by Schizochytrium sp. and its underlying mechanism

Article References: Ge, D., Luo, Y., Zhang, R., Hu, X., & Ren, L. (2025). Effect of light stress on the production of lipid compounds by Schizochytrium sp. and its underlying mechanism. Blue Biotechnology, 2(1), Article 8. https://doi.org/10.1186/s44315-025-00029-7

Image Credits: AI Generated

DOI: 10.1186/s44315-025-00029-7

Keywords: Schizochytrium, light stress, lipid biosynthesis, EPA, DHA, squalene, beta-carotene, astaxanthin, reactive oxygen species, transcriptomics, mevalonate pathway, marine biotechnology

The research team, led by scientists from Pondicherry University’s Andaman Campus, Nagasaki University, and Babasaheb Bhimrao Ambedkar Bihar University, systematically evaluated hundreds of studies to build the case that enzymes evolved under punishing marine conditions possess biochemical properties that terrestrial counterparts simply cannot replicate. Marine microbes thrive in salinities reaching five molar sodium chloride, temperatures spanning from subzero to above 100 degrees Celsius, and hydrostatic pressures exceeding 100 megapascals. These extremes have forged enzymes with exceptional thermostability, halotolerance, psychrophilicity, and catalytic efficiency, properties that translate directly into advantages for biomedical applications where conventional enzymes and drugs often fail.

The urgency of the search is underscored by sobering epidemiological data. A 2024 systematic analysis in The Lancet attributed 1.27 million direct deaths and 4.95 million associated deaths to bacterial antimicrobial resistance in 2019 alone, with forecasts projecting 1.91 million direct attributable deaths and 8.22 million associated deaths annually by 2050. Without accelerated intervention, the cumulative toll between 2025 and 2050 could reach 39 million deaths. Meanwhile, chronic inflammation quietly drives autoimmune disease, cardiovascular pathology, and neurodegeneration, while many existing cancer drugs suffer from off-target toxicity and eventual treatment resistance. The review positions marine enzymes as a fundamentally different therapeutic class capable of addressing all three challenges simultaneously.

In the inflammation arena, the standouts are superoxide dismutases, laccases, and chitinases. Superoxide dismutase catalyzes the dismutation of the superoxide anion into hydrogen peroxide and molecular oxygen, intercepting reactive oxygen species before they can generate the highly destructive peroxynitrite that damages lipids, proteins, and mitochondria. Marine versions, particularly the nickel-containing SOD found in cyanobacteria such as Prochlorococcus marinus, exhibit faster reaction rates and greater oxidative stress tolerance than conventional copper-zinc enzymes. In animal models of carrageenan-induced edema, marine SOD treatment reduced swelling, malondialdehyde levels, nitric oxide synthase activity, and leukocyte infiltration, while suppressing the master inflammatory transcription factor NF-κB and lowering secretion of the cytokines TNF-α, IL-1β, and IL-6. The commercially developed TetraSOD ingredient, derived from the microalga Tetraselmis chuii, demonstrated antioxidant and anti-inflammatory benefits in a rat model of metabolic syndrome, suggesting near-term applications in autoimmune, neuroinflammatory, and metabolic disorders.

Marine laccases, multicopper oxidases produced by fungi and bacteria in environments ranging from Antarctic waters to hypersaline lagoons, complement this antioxidant arsenal. Unlike peroxidases, which require hydrogen peroxide as a co-substrate and can become unstable during clinical use, laccases directly use molecular oxygen to oxidize phenolic inflammatory mediators. They also suppress NF-κB and MAPK signaling pathways in vitro, reducing IL-6 and TNF-α release. Chitinases add a third mechanism by hydrolyzing chitin into chitooligosaccharides that engage the pattern recognition receptors TLR9 and NOD2, triggering production of the anti-inflammatory cytokine IL-10. Recent work suggests the chitinase CHIT1 promotes microglial phagocytosis of amyloid plaques in models of Alzheimer’s disease, hinting at neuroprotective applications.

The oncology story is equally compelling, built on the principle of exploiting metabolic vulnerabilities unique to tumor cells. Marine-derived L-asparaginase, isolated from organisms including Bacillus tequilensis, Streptomyces species, and marine fungi, starves asparagine-dependent cancer cells by depleting extracellular L-asparagine, which activates p53-mediated apoptotic signaling and triggers mitochondrial outer membrane permeabilization, cytochrome c release, and caspase activation. One marine fungal asparaginase achieved an IC50 of 3.79 micrograms per milliliter against HCT-116, HepG2, and MCF-7 cancer cell lines, and importantly, marine variants show reduced glutaminase-associated toxicity and lower hypersensitivity potential compared with the Escherichia coli formulations currently used in leukemia therapy. Marine L-glutaminases from Halomonas meridiana and Halomonas aquamarina target glutamine-addicted colorectal tumors, with reported IC50 values of 7.0 and 13.2 micrograms per milliliter against LS 174 T and HCT-116 cells respectively, inducing endoplasmic reticulum stress and mitochondrial damage through cyclophilin A-caspase signaling.

Beyond nutrient starvation, marine enzymes attack tumors through oxidative and structural routes. Laccases from marine Streptomyces generate reactive oxygen species that preferentially damage tumor mitochondria, activating Bax, releasing cytochrome c, and downregulating the anti-apoptotic protein Bcl-2, while oxidase-inspired nanozyme systems have demonstrated ferroptosis-mediated tumor suppression with negligible systemic toxicity in preclinical models. Alkaline proteases from marine Streptomyces and Pseudoalteromonas species degrade collagen, fibronectin, and laminin in the tumor extracellular matrix, disrupting integrin signaling, softening stromal mechanics, and interfering with the invasive architecture that shields tumors from immune surveillance and drug penetration. Because tumor and normal tissues differ in nutrient dependence, redox balance, and matrix composition, these enzyme strategies achieve a degree of selectivity that conventional chemotherapy struggles to match.

The most dramatic results, however, may lie in the fight against antimicrobial resistance. Biofilms, the sticky extracellular polymeric fortresses that pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus construct to shield themselves from antibiotics and immune attack, are a leading cause of chronic, treatment-refractory infections. Marine alginate lyases from Flavobacterium, Sphingomonas, and Pseudoalteromonas carrageenovora specifically cleave the alginate strands of Pseudomonas biofilms, and when combined with the antibiotic ceftobiprole, achieved biofilm reductions of 60 to 69 percent, dramatically enhancing antibiotic penetration compared with antibiotic treatment alone. Serine and alkaline proteases bearing the catalytic Ser-His-Asp triad degrade bacterial surface proteins and biofilm matrix components, lowering minimum inhibitory concentrations of co-administered antibiotics, while marine chitinases breach fungal cell walls and affect Gram-positive bacteria. Collagenases and thiol proteases further destabilize established biofilms in models of persistent infection.

Yet the path from laboratory promise to clinical reality remains steep. Most marine enzymes evolved for conditions far from the human body’s 37 degrees Celsius and near-neutral pH, so protein engineering, PEGylation, and nanoparticle encapsulation are often needed to ensure physiological compatibility. The vast majority of ocean microbes cannot be cultured in the laboratory, a problem known as the great plate count anomaly, locking countless candidate enzymes within microbial dark matter, though metagenomics, single-cell genomics, and functional screening are now bypassing the need for cultivation. No pharmacokinetic profiles, immunogenicity assessments, or clinical trial data yet exist for these candidates, and regulatory pathways for marine-derived enzyme therapeutics remain underdeveloped. Directed evolution and recombinant expression systems have already demonstrated more than 100-fold improvements in catalytic efficiency for engineered protein systems, and artificial intelligence-guided discovery promises to accelerate identification of optimal candidates.

The review’s authors argue that the coming decade offers a transformational window if researchers prioritize preclinical validation, dose optimization, and early-phase human trials for the most advanced candidates, particularly asparaginase isoforms and alginate lyases. They also stress that bioprospecting must proceed under the Nagoya Protocol and ocean conservation frameworks to ensure that the exploitation of these genetic resources protects the very biodiversity that produced them. With antimicrobial resistance projected to claim tens of millions of lives by mid-century and inflammatory and oncological disease burdens rising worldwide, the humble enzymes of ocean microbes, refined by eons of evolutionary pressure in Earth’s most hostile environments, may prove to be among the most valuable biomedical resources humanity has yet to fully harvest.

Subject of Research: Marine microbial enzymes as therapeutic agents against chronic inflammation, cancer, and antimicrobial resistance

Article Title: Marine microbial enzymes as the next frontier in combating chronic inflammation, cancer, and global antimicrobial resistance

Article References: Kumar, A., Soratur, A., Kumar, S., Sarkar, A., Thiruchitrambalam, G., & Venmathi Maran, B. A. (2026). Marine microbial enzymes as the next frontier in combating chronic inflammation, cancer, and global antimicrobial resistance. Discover Oceans, 3(1), Article 49. https://doi.org/10.1007/s44289-026-00161-1

Image Credits: AI Generated

DOI: 10.1007/s44289-026-00161-1

Keywords: marine microbial enzymes, extremozymes, antimicrobial resistance, chronic inflammation, superoxide dismutase, L-asparaginase, alginate lyase, biofilm disruption, cancer therapy, marine biotechnology, NF-kB signaling, bioprospecting

The research arrives at a moment when maritime spatial planning, or MSP, has moved from an abstract academic concept to a binding legal obligation in many coastal states. The European Union’s MSP Directive, the marine spatial plans emerging across Asia, Africa and Latin America, and the target under the United Nations Convention on Biological Diversity to protect thirty percent of the ocean by 2030 all demand planning processes that can weigh industrial development against ecological integrity. Yet in practice, planners frequently lack a structured way to answer a deceptively simple question: which sectors depend on which ecosystem services, and what happens to human well-being when those services are degraded or displaced?

The framework addresses this gap by treating blue economy sectors not as isolated actors but as components of a coupled social-ecological system. Each sector, whether it is offshore renewable energy, commercial fishing, maritime transport, aquaculture, tourism or emerging industries such as floating infrastructure and deep-sea resource extraction, is mapped against a portfolio of ecosystem services drawn from established classification systems. These include provisioning services such as food and raw materials, regulating services such as climate regulation and coastal protection, and cultural services such as recreation, heritage and identity. By making these dependencies and impacts explicit, the framework turns what has often been an implicit, intuition-driven judgment into a transparent and auditable analytical structure.

What distinguishes the approach from earlier attempts at integration is its insistence on the socio-economic dimension. Maritime spatial planning has historically been dominated by ecological and engineering considerations, with human dimensions added late in the process or treated as constraints on otherwise technical decisions. The new framework elevates socio-economic priorities to a co-equal pillar of the analysis. Employment, food security, income distribution, cultural values, gender equity and regional development objectives are positioned as the evaluative criteria against which the consequences of sector-service interactions are judged. This means that a planning decision is no longer assessed only by its effect on a habitat or a species population, but by its cascading consequences for the livelihoods and priorities that those ecological functions underpin.

Technically, the framework operates as a structured chain of linkage analysis. In the first stage, sectors are characterized by their spatial footprint, resource demands and pressures on the marine environment, including physical disturbance, pollution, noise, greenhouse gas emissions and biological impacts. In the second stage, ecosystem services are identified and located, often using spatially explicit data layers that show where services are generated and who benefits from them. The third stage constructs the dependency and impact matrices, recording for each sector-service pair whether the sector relies on the service, degrades it, enhances it or competes with other sectors for it. The fourth stage connects these interactions to socio-economic priorities through indicators that can be monitored over time, allowing planners to track whether a given allocation of ocean space is delivering on declared policy goals.

This chain-of-linkages logic has significant practical advantages for planning authorities. It enables cumulative impact assessment to move beyond simply summing pressures and instead to trace how combined pressures alter service flows and, ultimately, human welfare. It supports scenario analysis, so that planners can compare, for example, an aggressive offshore wind build-out against a more diversified allocation that reserves space for small-scale fisheries and coastal protection habitats. It also creates a common language for stakeholders who often talk past one another. A fishing cooperative, an energy developer and a conservation agency can each locate their concerns within the same framework, which reduces the translation problems that have historically made marine planning negotiations slow and adversarial.

The framework is also designed with trade-off analysis at its core. The ocean cannot simultaneously maximize every use in every location, and the concept of the blue economy has been criticized, in some quarters, for promising growth without acknowledging the hard choices that growth implies. By forcing explicit recognition of which services are lost, degraded or gained under alternative planning scenarios, and by tying those changes to named socio-economic priorities, the framework makes trade-offs visible rather than hiding them in aggregated cost-benefit figures. This transparency matters for legitimacy. Coastal communities that see how their priorities were weighed, and where their interests were traded against others, are more likely to accept planning outcomes than communities confronted with decisions that appear to have emerged from a black box.

The study speaks directly to several urgent global policy conversations. The sustainable blue economy agenda promoted by international organizations envisions ocean industries as engines of development, but that vision is credible only if the ecological base of the economy is maintained. The framework provides a mechanism for operationalizing this conditionality: sectors can grow, but the analysis shows where growth erodes the service foundation on which other sectors and communities depend. Similarly, ecosystem-based management, long a guiding principle in marine policy, gains a concrete implementation pathway. Rather than remaining an aspiration, ecosystem-based management becomes a set of defined linkages, indicators and decision points that can be embedded in statutory planning processes.

The timing of the publication is notable. Global commitments to offshore renewable energy are accelerating, aquaculture is the fastest-growing food production sector in the world, and shipping volumes continue to rise even as nations pledge to decarbonize maritime transport. Meanwhile, the recently agreed international agreement on biodiversity beyond national jurisdiction, together with expanding networks of marine protected areas, is adding new layers of regulation to ocean space. Planning systems that were built for a quieter ocean now face simultaneous demands for industrial expansion, biodiversity protection and climate adaptation. The framework offers planners a way to integrate these demands systematically, rather than resolving conflicts case by case after they erupt.

For researchers, the framework opens a research agenda as much as it closes one. The authors’ structure invites empirical application in specific seascapes, where data on service distribution, sector pressures and socio-economic indicators can populate the linkage matrices and reveal whether the framework performs as intended under real institutional conditions. It also invites methodological development: the integration of ecosystem service models with ocean observation systems, the use of participatory mapping to capture local and Indigenous knowledge of service flows, and the coupling of the framework with optimization and simulation tools that can search for planning allocations satisfying multiple priorities at once. As more jurisdictions adopt legally binding marine plans, the demand for methods that can demonstrate the consequences of those plans for both ecosystems and people will only grow. This study provides a credible, general-purpose scaffold for meeting that demand, and its true test will be how quickly it moves from the journal page into the planning rooms where the ocean’s future is actually decided.

Subject of Research: A framework linking blue economy sectors to ecosystem services and socio-economic priorities for integrated maritime spatial planning

Article Title: Linking blue economy sectors to ecosystem services and socio-economic priorities: a framework for integrated maritime spatial planning

Article References: Pegorelli, C., Rayo-Luengo, S., Garcia-Onetti, J., de Andrés, M., Stojanovic, I., & Sanabria, J. G. (2026). Linking blue economy sectors to ecosystem services and socio-economic priorities: a framework for integrated maritime spatial planning. npj Ocean Sustainability. https://doi.org/10.1038/s44183-026-00238-6

Image Credits: AI Generated

DOI: 10.1038/s44183-026-00238-6

Keywords: blue economy, maritime spatial planning, ecosystem services, ocean governance, socio-economic priorities, marine policy, offshore renewable energy, aquaculture, ecosystem-based management, npj Ocean Sustainability, Linking, blue

The core idea is deceptively simple. Rather than classifying seaweeds only by taxonomy or by their current commercial status, the framework characterizes each species by measurable functional traits: morphological features such as thallus size and branching, physiological features such as photosynthetic rates and nutrient uptake kinetics, and life-history features such as reproductive strategy and growth seasonality. In terrestrial agriculture, this trait-based approach has underpinned decades of crop improvement and ecological screening, allowing scientists to predict how a plant will perform under specific conditions without having to trial every individual genotype. The authors contend that seaweed science is now mature enough to apply the same logic, turning a scattered body of species-specific observations into a coherent, comparative discipline.

The need for such a framework becomes clear when one considers the structure of the seaweed farming industry. Global production is overwhelmingly concentrated in a handful of genera, including the kelp Saccharina and Undaria, the red algae Pyropia, Eucheuma, Kappaphycus, and Gracilaria, and the green alga Ulva. These cultivated species were largely domesticated from wild populations selected for availability and market demand rather than for optimized performance. Meanwhile, thousands of seaweed species remain uncultivated, many of which may possess traits, such as tolerance to warmer water, resistance to disease, rapid growth, or valuable biochemical compositions, that could make them superior candidates for future farming systems, particularly as ocean temperatures rise and cultivation expands into new biogeographic regions.

At the heart of the proposed approach is the recognition that no single trait determines success in aquaculture. A fast-growing species that cannot withstand wave exposure is a poor candidate for open-ocean farms; a hardy species with slow growth may never achieve commercial yields. Trait-based characterization allows these trade-offs to be made explicit. By compiling data on traits such as growth rate, temperature and salinity tolerance, nutrient requirements, epiphyte and pathogen susceptibility, ease of reproduction in hatcheries, and the mechanical properties of the thallus that determine how well a seaweed handles farm infrastructure, researchers can build comparative profiles that reveal which species are most likely to thrive under particular farming conditions and for particular markets.

The framework also speaks directly to one of the most pressing challenges in the field: climate resilience. Many of today’s workhorse species are cultivated near the thermal edges of their tolerance, and marine heatwaves have already caused significant crop losses in several producing regions. Selecting new candidates on the basis of thermal tolerance traits, rather than historical yield alone, could help the industry stay ahead of shifting ocean conditions. Similarly, as interest grows in offshore cultivation, where wave action and depth impose demands that nearshore farms do not, traits such as thallus robustness and attachment strength become decisive selection criteria that conventional species lists simply cannot capture.

Beyond environmental matching, trait-based screening can illuminate a species’ potential end-use. Seaweeds are farmed for wildly different purposes: nori for direct human consumption, carrageenan and agar-producing reds for hydrocolloid extraction, kelps for food ingredients and increasingly for applications in livestock feed and methane reduction. The biochemical profile of a species, its polysaccharide content, protein levels, pigment composition, and secondary metabolites, is itself a set of functional traits. Incorporating these biochemical characteristics into the framework means that candidate selection can be aligned with market opportunities from the outset, rather than discovering after years of agronomic development that a species is agronomically suitable but commercially unattractive.

The authors emphasize that building such a framework requires addressing significant data gaps. Trait information for seaweeds is patchy, fragmented across decades of phycological literature, and often measured with inconsistent methods that make cross-species comparison difficult. For many candidate species, even basic parameters such as maximal growth rate or reproductive biology in cultivation are unknown. The paper calls for coordinated efforts to standardize trait measurements, compile existing data into accessible databases, and prioritize trait characterization for species that show early promise. This is a familiar challenge in the history of trait-based ecology, where the value of comparative frameworks grew directly out of sustained investment in standardized measurement across research groups.

Another important dimension of the framework is its potential to support responsible innovation. Introducing new species into cultivation carries ecological risks, including the possibility of escapes, competition with native flora, and disease transmission. The authors argue that trait-based evaluation can incorporate risk-relevant traits, such as a species’ invasive potential, its reproductive dispersal capacity, and its host status for known seaweed pathogens, alongside performance traits. This integrated screening could help regulators and farmers distinguish between candidates whose domestication is ecologically prudent and those whose traits raise red flags, embedding biosafety into the earliest stages of candidate selection rather than treating it as an afterthought.

The social and economic geography of seaweed farming also figures in the analysis. A large share of global production occurs among smallholder coastal communities in Asia, and any expansion of the industry into new species and new regions will need to respect local capacities, infrastructure, and market structures. Traits such as the simplicity of a species’ cultivation cycle, the availability of seedstock, and the labor intensity of farm operations are directly relevant to whether a candidate species can be adopted by small-scale farmers. A framework that formalizes these practical traits alongside biological ones helps ensure that scientific selection translates into real-world adoption rather than remaining an exercise in laboratory optimization.

Looking forward, the trait-based approach opens doors to more quantitative and even predictive tools. As trait databases grow, statistical and machine-learning methods could identify combinations of traits that predict cultivation success, allowing researchers to screen large numbers of candidate species cheaply before committing resources to farm trials. The same data could guide selective breeding programs within promising species, identifying heritable traits that respond to improvement, much as crop breeders have done on land. In this sense, the framework is not merely a sorting exercise but a foundation for the deliberate domestication of a new generation of seaweed crops, bringing a level of intentionality to aquaculture that has so far been rare in the sector.

The broader significance of the work lies in its reframing of what seaweed farming could become. Today’s industry, for all its impressive growth, rests on a narrow biological base that is vulnerable to disease, climate shocks, and market fluctuations. Diversification is widely recognized as essential, but diversification without a principled selection process risks wasted investment and ecological harm. A trait-based framework offers a shared language for researchers, farmers, investors, and regulators to evaluate candidates systematically, compare trade-offs transparently, and prioritize the species most likely to succeed under the conditions of tomorrow’s oceans. As pressure mounts to expand sustainable marine food production, the ability to choose the right seaweed for the right place and purpose may prove to be one of the most consequential tools the industry acquires.

The analogy with terrestrial crop science is instructive because it highlights how long the payoff horizon for trait-based approaches can be. In agriculture on land, systematic trait screening preceded the green revolution’s yield gains by decades, and the seaweed sector is effectively at the beginning of that trajectory. Most cultivated seaweed genera have undergone little deliberate genetic improvement, meaning there may be substantial untapped potential even within currently farmed species once their traits are properly quantified and compared.

The framework also arrives at a moment when demand for seaweed products is diversifying beyond traditional food uses. Emerging applications, from biostimulants to alternative proteins, each favor different biochemical and physiological profiles, which strengthens the case for matching species to end-use through explicit trait data rather than trial and error. A species rich in specific polysaccharides, for example, may justify cultivation under conditions that would be uneconomical for a general-purpose food crop.

Finally, the perspective underscores a cultural shift within phycology itself. Much existing knowledge of seaweed biology resides in ecological studies of wild populations rather than in agronomic trials, and the proposed framework offers a route to translate that ecological understanding into cultivation insight. By treating traits as the common currency between wild ecology and farm performance, researchers can begin predicting how uncultivated species might behave in farm settings before expensive domestication programs begin, potentially shortening the path from ocean to aquaculture for promising new candidates.

Subject of Research: Using a trait-based framework to characterize farmed seaweeds and guide selection of new candidates

Article Title: Using a trait-based framework to characterize farmed seaweeds and guide selection of new candidates

Article References: Fong, C. R., Fong, P., & Froehlich, H. E. (2026). Using a trait-based framework to characterize farmed seaweeds and guide selection of new candidates. npj Ocean Sustainability. https://doi.org/10.1038/s44183-026-00239-5

Image Credits: AI Generated

DOI: 10.1038/s44183-026-00239-5

Keywords: trait-based, framework, characterize, farmed, seaweeds, guide, selection, candidates, scientific research